OptimizeRx Corp. (NASDAQ: OPRX), a provider of healthcare technology solutions for life sciences companies, announced it has entered into a $35 million senior secured credit facility with Fifth Third Bank. The facility consists of a $25 million term loan and a $10 million revolving credit facility that was undrawn at closing. Roth Capital Partners served as financial advisor on the transaction.
This financing provides OptimizeRx with additional capital to support its growth initiatives, including investments in its artificial intelligence-driven platform that connects life science brands with patients and healthcare providers. The company's platform combines tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver hyper-local engagement.
OptimizeRx's technology aims to bridge the gap between healthcare provider and direct-to-consumer strategies, enabling synchronized marketing solutions that facilitate faster treatment decisions and improved patient outcomes. The company emphasizes a commitment to privacy-safe, patient-centric technology.
Headquartered in Waltham, Massachusetts, OptimizeRx partners with leading pharmaceutical and life sciences companies to transform the healthcare landscape. The credit facility from Fifth Third Bank, a major U.S. regional bank, signals confidence in the company's business model and growth prospects.
For more information about OptimizeRx and its solutions, visit www.optimizerx.com.
The announcement was disseminated by MissionIR, a communications platform within the Dynamic Brand Portfolio @IBN that provides syndicated content to enhance visibility for companies. MissionIR offers access to wire solutions via InvestorWire, article syndication to over 5,000 outlets, and social media distribution.
This credit facility provides OptimizeRx with financial flexibility to pursue its strategic objectives in the competitive healthcare technology market. The undrawn revolving credit line offers additional liquidity for future needs.
